Unlock effective strategies for managing double patenting risk. Learn from landmark cases and current USPTO practice to safeguard your patent portfolio term.
In today’s evolving patent landscape, understanding obviousness-type double patenting (ODP) is critical to securing and maintaining strong intellectual property rights. The Federal Circuit’s evolving case law in the URAA era from Gilead to Novartis and most recently, Cellect and Allergan has significant implications for patent protection strategies.
Join our speakers in this CLE webinar as they explore the latest developments in double patenting jurisprudence and share strategic insights to mitigate risks and optimize patent prosecution. The discussion will cover proactive measures such as removing unnecessary terminal disclaimers before issuance, leveraging patent term extension (PTE), and addressing the risk of ODP to patent term adjustment (PTA). It will also highlight key prosecution strategies, IP portfolio audits to identify potential ODP challenges, and the use of reissue applications to correct PTA-related vulnerabilities.
Live and Recorded CLE & CPE Webcasts in the Legal, Tax, Finance, Risk, Compliance and Human Resources Industries
Founded in November 2006, The Knowledge Group has established itself as a premier eLearning hub for Continuing Legal Education (CLE), Continuing Professional Education (CPE), and technology-focused webcasts. We equip lawyers, accountants, and industry professionals with expert-driven insights, timely regulatory updates, and practical strategies to help them stay ahead in an ever-evolving landscape.
Partner at Maier & Maier, PLLC
Mr. Bahr is a Partner at Maier & Maier PLLC. Mr. Bahr is an authority on patent laws, rules, and examining procedure, and his expertise includes post-issuance proceedings at the United States Patent Office (USPTO), advising attorneys and clients on complex patent prosecution matters, patent litigation strategy, and USPTO patent policy, practice and procedure. Mr. Bahr previously served as the Deputy Commissioner for Patent Examination Policy at the USPTO, and was involved in numerous patent-related rule-makings, including implementation of the American Inventors Protection Act of 1999 and the Leahy-Smith America Invents Act. Mr. Bahr was awarded two Department of Commerce Gold Medals and two Department of Commerce Bronze Medals.
Partner at Crowell & Moring LLP
Deborah H. Yellin is a partner at Crowell & Moring’s Washington, D.C. office, specializing in patent procurement, intellectual property portfolio management, and U.S. Patent and Trademark Office post-grant proceedings. She advises on Patent Term Extensions and manages global patent portfolios for diverse clients. She has notable experience in Hatch-Waxman and BPCIA cases, securing significant victories in IPR challenges. Admitted to the District of Columbia and Virginia State Bars, and registered with the USPTO.
Associate at Arnold & Porter Kaye Scholer LLP
Dr. Alice Ho is an intellectual property attorney with Arnold & Porter in Washington, D.C. With a focus on biotechnology, medical device, pharmaceutical, and life sciences companies, Dr. Ho’s practice includes patent prosecution, handling matters before the Patent Trial and Appeal Board, Hatch-Waxman litigation, and other litigation before Federal District courts, as well as advising on the intellectual property aspects of transactions. Dr. Ho received her Ph.D. from The Johns Hopkins University School of Medicine. She has been recognized by LMG Life Sciences and Legal 500, and she is an active member of the PTAB Bar Association, serving as a Committee Vice Chair of the Women’s Committee.
